Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012–2016

BACKGROUND: Antimicrobial-resistant Neisseria gonorrhoeae is a major public health threat. The Centers for Disease Control and Prevention (CDC) recommends ceftriaxone 250 mg plus azithromycin (AZM) 1 g for gonorrhea treatment. Resistance to AZM could affect gonorrhea control efforts. METHODS: Using...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Barbee, Lindley A, Soge, Olusegun O, Katz, David A, Dombrowski, Julia C, Holmes, King K, Golden, Matthew R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848236/
https://ncbi.nlm.nih.gov/pubmed/29045604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix898
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia